Cumberland Pharmaceuticals (CPIX) Asset Utilization Ratio (2011 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Asset Utilization Ratio came in at 0.57 in Q1 2026, little changed year-on-year from 0.56 in Q1 2025, and down 9.05% quarter-over-quarter from 0.62 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Asset Utilization Ratio across 16 years of filings, most recently posting 0.57 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.57, changed 0.5% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.57 (changed 0.5% YoY), and the FY2025 annual result was 0.58, up 21.39% from the prior year.
- Asset Utilization Ratio came in at 0.57 for Q1 2026 at Cumberland Pharmaceuticals, down from 0.62 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.62 in Q4 2025 to a low of 0.4 in Q2 2022.
- The 5-year median for Asset Utilization Ratio is 0.47 (2024), against an average of 0.5.
- Across the five-year window, Asset Utilization Ratio retreated 6.76% in 2022 and soared 30.21% in 2025, its largest moves.
- Cumberland Pharmaceuticals' Asset Utilization Ratio stood at 0.46 in 2022, then grew by 2.02% to 0.47 in 2023, then grew by 6.55% to 0.5 in 2024, then advanced by 25.49% to 0.62 in 2025, then dropped by 9.05% to 0.57 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.57 (Q1 2026), 0.62 (Q4 2025), and 0.62 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.43 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.62 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.43 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.48 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.65 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.37 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.36 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.07 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.68 |
| 10 | Cumberland Pharmaceuticals | 86.62 Mn | 75.28 Mn | 7.20 Mn | 0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.57 |
| Dec 31, 2025 | 0.62 |
| Sep 30, 2025 | 0.62 |
| Jun 30, 2025 | 0.61 |
| Mar 31, 2025 | 0.56 |
| Dec 31, 2024 | 0.50 |
| Sep 30, 2024 | 0.47 |
| Jun 30, 2024 | 0.47 |
| Mar 31, 2024 | 0.48 |
| Dec 31, 2023 | 0.47 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.45 |
| Mar 31, 2023 | 0.44 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.40 |
| Mar 31, 2022 | 0.40 |
| Dec 31, 2021 | 0.42 |
| Sep 30, 2021 | 0.43 |
| Jun 30, 2021 | 0.43 |